Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

Xuqi Sun,1– 3,* Dandan Hu,1,2,* Zhoutian Yang,1,2 Zheng Liu,3,4 Juncheng Wang,1,2 Jinbin Chen,1,2 Li Xu,1,2 Zhongguo Zhou,1,2 Minshan Chen,1,2 Yaojun Zhang1,2 1Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer...

Full description

Bibliographic Details
Main Authors: Sun X, Hu D, Yang Z, Liu Z, Wang J, Chen J, Xu L, Zhou Z, Chen M, Zhang Y
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
immunotherapy
hepatitis b virus
viral load
Online Access:https://www.dovepress.com/baseline-hbv-loads-do-not-affect-the-prognosis-of-patients-with-hepato-peer-reviewed-article-JHC

Internet

https://www.dovepress.com/baseline-hbv-loads-do-not-affect-the-prognosis-of-patients-with-hepato-peer-reviewed-article-JHC

Similar Items